- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Current Price: $57.18
William Blair has increased the company’s price target due to increased confidence in BMN-701 after the Lysosomal Disease Network WORLD Symposium. The firm still names BioMarin as a top pick for 2013 and reiterates its Outperform rating on stock.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.